ERBB2 and neoplasm: There were no statistically significant differences between the intermediate- and high-risk groups regarding age at diagnosis, sex, ECOG performance status, prior surgery for the primary tumor, tumor grade, HER2 (Human epidermal growth factor receptor 2) status, or MMR status.